RHYTHM Biosciences Ltd (RHY) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.037x

Based on the latest financial reports, RHYTHM Biosciences Ltd (RHY) has a cash flow conversion efficiency ratio of -1.037x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.22 Million ≈ $-1.57 Million USD) by net assets (AU$2.14 Million ≈ $1.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see RHYTHM Biosciences Ltd (RHY) total market value for the company's overall valuation and market capitalisation.

RHYTHM Biosciences Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how RHYTHM Biosciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

RHYTHM Biosciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RHYTHM Biosciences Ltd ranked by their cash flow conversion efficiency. Explore RHYTHM Biosciences Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Leyand International Tbk JK:LAPD	0.140x
Wanted Lab Inc. KQ:376980	0.031x
Lancashire Holdings Ltd LSE:LRE	0.018x
ISA Holdings Ltd JSE:ISA	0.239x
Cavendish Hydrogen ASA OL:CAVEN	-0.092x
Wolftank Group AG VI:WOLF	0.157x
Dunelm Group PLC LSE:DNLM	0.128x
Varopakorn Public Company Limited BK:VARO	0.381x

Annual Cash Flow Conversion Efficiency for RHYTHM Biosciences Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of RHYTHM Biosciences Ltd from 2017 to 2025. View RHY live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$659.89K ≈ $466.92K	AU$-2.92 Million ≈ $-2.07 Million	-4.427x	+37.45%
2024-06-30	AU$867.17K ≈ $613.58K	AU$-6.14 Million ≈ $-4.34 Million	-7.077x	-497.55%
2023-06-30	AU$5.87 Million ≈ $4.16 Million	AU$-6.96 Million ≈ $-4.92 Million	-1.184x	-40.49%
2022-06-30	AU$7.37 Million ≈ $5.22 Million	AU$-6.21 Million ≈ $-4.40 Million	-0.843x	+73.37%
2021-06-30	AU$1.71 Million ≈ $1.21 Million	AU$-5.40 Million ≈ $-3.82 Million	-3.165x	-112.71%
2020-06-30	AU$1.84 Million ≈ $1.30 Million	AU$-2.74 Million ≈ $-1.94 Million	-1.488x	-195.92%
2019-06-30	AU$5.85 Million ≈ $4.14 Million	AU$-2.94 Million ≈ $-2.08 Million	-0.503x	-152.79%
2018-06-30	AU$8.30 Million ≈ $5.87 Million	AU$-1.65 Million ≈ $-1.17 Million	-0.199x	-2177166.56%
2017-06-30	AU$1.42 Million ≈ $1.01 Million	AU$-13.00 ≈ $-9.20	0.000x	--

About RHYTHM Biosciences Ltd

AU:RHY Australia Diagnostics & Research

Market Cap

$19.03 Million

AU$26.89 Million AUD

Market Cap Rank

#25366 Global

#1081 in Australia

Share Price

AU$0.08

Change (1 day)

+0.00%

52-Week Range

AU$0.08 - AU$0.26

All Time High

AU$2.00